As an Executive Agency of the Department of Health and Social
Care, the MHRA have an important role in the delivery of the
Government's priorities to ensure people live healthier and
longer lives, including its mission to build an NHS fit for the
future, driving innovation in the life sciences, and accelerating
regulatory approval.
The Agency's core mission remains unchanged – to protect and
promote public health by ensuring that healthcare products, used
every day by millions of people in the UK, work and are
acceptably safe. We put patients at the heart of everything we
do, and increasingly involve patients in our decision-making.
Building on progress since the launch of our 3-year corporate
plan in 2023, the targets we have been delivering against since 1
April 2024 involve making significant improvements to ensure high
quality and sustainable regulatory and scientific services that
operate to predictable timescales.
The Business Plan also reflects the exciting developments in
regulatory science, which inform the Agency's plan to create a UK
network of Centres of Excellence in Regulatory Science.
Dr June Raine, Chief Executive of the MHRA,
said:
To take full advantage of today's exciting developments in
science and technology for the benefit of patients, we will focus
on facilitating access to innovative new products while also
ensuring continued access to well-established healthcare products
that are the backbone of NHS healthcare.
We will continue to invest in our talented staff by creating
satisfying roles and careers, implement an exciting and robust
talent management programme, promote diversity and inclusivity
and continue to grow as an organisation where every individual
can reach their full potential and deliver excellent performance.
For us to deliver these outcomes who use our services, we have
built our latest plan around four strategic priorities:
- Maintain public trust through transparency and proactive
communication, including working to address health inequalities
- Enable healthcare access to safe and effective medical
products
- Deliver scientific and regulatory excellence through
strategic partnerships
- Become an agency where people flourish alongside a responsive
customer service culture
Underpinning the agency's service optimisation will be our two
new regulatory IT systems, SafetyConnect and RegulatoryConnect.
SafetyConnect will ensure we continue to respond effectively to
new safety signals throughout the product lifecycle, while
RegulatoryConnect will modernise our existing management systems
and support state-of-the-art interactions with stakeholders.
Delivering on these priorities will also fuel UK Life Sciences
growth and contribute to the UK's pandemic preparedness,
underscoring our commitment to national resilience. The agency
will continue to operate financial sustainability and support
work towards net Zero and environmental sustainability in the
healthcare products industry.
Notes to editors
- The MHRA's 2024/25 Business Plan has been published
here.
- The MHRA is an executive agency of the Department of Health
and Social Care.
